JIM CRAMERDepression Ahead: Cramer's 'Mad Money' Recap (Friday 4/3/20)By Scott RuttApr 3, 2020 8:58 PM EDT
JIM CRAMERGrasping at Straws?: Cramer's 'Mad Money' Recap (Thursday 4/2/20)By Scott RuttApr 2, 2020 9:09 PM EDT
PRESS RELEASESAbbVie To Host First-Quarter 2020 Earnings Conference CallBy PR NewswireApr 2, 2020 8:00 AM EDT
PRESS RELEASESAbbVie Donates $35 Million For COVID-19 Relief To Support Healthcare Systems, Patients And CommunitiesBy PR NewswireMar 31, 2020 7:24 PM EDT
EARNINGS2020 Earnings Calendar: When Do Top Companies Report This Quarter?By Steve FiorilloMar 26, 2020 1:12 PM EDT
PRESS RELEASESAbbVie And Allergan Sign Consent Decree Agreement With Federal Trade Commission Staff On Pending TransactionBy PR NewswireMar 17, 2020 4:30 PM EDT
JIM CRAMERNo Business As Usual: Cramer's 'Mad Money' Recap (Thursday 3/12/20)By Scott RuttMar 12, 2020 9:36 PM EDT
JIM CRAMERWhere's the Risk?: Cramer's 'Mad Money' Recap (Tuesday 3/10/20)By Scott RuttMar 10, 2020 8:54 PM EDT
PRESS RELEASESAbbVie Partnering With Global Authorities To Determine Efficacy Of HIV Drug In Treating COVID-19By PR NewswireMar 9, 2020 8:45 AM EDT
PRESS RELEASESAbbVie And Allergan Receive Final European Approval To Close Pending TransactionBy PR NewswireMar 3, 2020 8:00 AM EST
MARKETSMarket Meltdown: How I’m Trading It and What the Fed, Treasury and SEC Should Do NowBy Stephen GuilfoyleFeb 28, 2020 11:55 AM EST
PRESS RELEASESAbbVie To Present At The Cowen 40th Annual Health Care ConferenceBy PR NewswireFeb 19, 2020 8:00 AM EST
PRESS RELEASESSHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation Of The Board Of Directors And Officers Of AbbVie Inc. - ABBVBy PR NewswireFeb 18, 2020 5:03 PM EST
JIM CRAMERColored by Coronavirus: Cramer's 'Mad Money' Recap (Friday 2/14/20)By Scott RuttFeb 14, 2020 8:32 PM EST
PRESS RELEASESAbbVie To Present At The SVB Leerink 9th Annual Global Healthcare ConferenceBy PR NewswireFeb 11, 2020 8:00 AM EST
MARKETSNasdaq, S&P 500 Close at Record Highs as Wall Street Assesses Jump in Coronavirus DeathsBy Joseph WoelfelFeb 10, 2020 2:28 PM EST
INVESTINGAllergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1By Martin BaccardaxFeb 10, 2020 9:31 AM EST
LATEST NEWSUpdates on Wuhan Coronavirus: Over 40,000 Infected, Death Toll Tops 900By Adam SmithFeb 9, 2020 6:44 PM EST
MARKETSStocks Close Lower After Jobs Report and as Coronavirus Worries LingerBy Joseph WoelfelFeb 7, 2020 2:52 PM EST
INVESTINGAbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost SalesBy Martin BaccardaxFeb 7, 2020 10:20 AM EST
MARKETSJobs Report, Credit Suisse, Uber, Activision and 'Friends' - 5 Things You Must Know FridayBy Joseph WoelfelFeb 7, 2020 7:30 AM EST
INVESTINGAbbVie Gains Pre-Earnings on Analyst Nod, Coronavirus Drug DemandBy M. Corey GoldmanFeb 6, 2020 10:54 AM EST
